yh14618
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2012 (NCT01526330)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yh14618
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02320019 | Phase 2 | Mar 1, 2015 | Yuhan Pharmaceutical Company |
| NCT01526330 | Phase 1/Phase 2 (Phase 2) | May 1, 2012 | Kangbuk Samsung Hospital, Yuhan Pharmaceutical Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuhan Pharmaceutical Company | For profit | 2 | 2 | 1 | 2012 |
| Kangbuk Samsung Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1